Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Megraud

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Gut|October 17, 2007
Helicobacter pylori and antibiotic resistanceFrancis Megraud
Gastroenterology|September 15, 2007
Eradication therapy for Helicobacter pyloriNimish Vakil, Francis Megraud
Helicobacter|November 18, 2020
Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapyDavid Y Graham, Francis Megraud
Lancet (London, England)|October 23, 2016
Towards effective empirical treatment for Helicobacter pylori eradicationFrancis Megraud, Javier P Gisbert
Diagnostics (Basel, Switzerland)|July 14, 2023
Reply to Kocsmár, É.; Lotz, G. Comment on "Skrebinska et al. Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for <i>Helicobacter pylori</i> Detection? <i>Diagnostics</i> 2022, <i>12</i>, 133"Ilva Daugule, Francis Megraud, Marcis Leja
Helicobacter|August 13, 2025
Helicobacter pylori Infection in Children Versus Adults, Differences in Management Guidelines: Risks and Benefits of Treatment in ChildhoodMatjaž Homan, Zrinjka Mišak, Francis Megraud, et al.
Helicobacter|August 3, 2006
Bioinformatic analysis of Helicobacter pylori XGPRTase: a potential therapeutic targetMegan Duckworth, Armelle Ménard, Francis Megraud, et al.
Gut|March 6, 2023
Empiric use of standard triple therapy in <i>Helicobacter pylori</i> eradication does not require readjustment in the clarithromycin resistance cut-off pointPeter Malfertheiner, Francis Megraud, Theodore Rokkas, et al.
Acta Pharmaceutica (Zagreb, Croatia)|October 13, 2009
Metalloantibiotics: synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pyloriAnwar R Shaikh, Rajani Giridhar, Francis Megraud, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 17, 2005
Detection of mutations associated with macrolide resistance in thermophilic Campylobacter spp. by real-time PCRSylvie Vacher, Armelle Menard, Elisabeth Bernard, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Gut|October 17, 2007
Helicobacter pylori and antibiotic resistanceFrancis Megraud
Gastroenterology|September 15, 2007
Eradication therapy for Helicobacter pyloriNimish Vakil, Francis Megraud
Helicobacter|November 18, 2020
Classification system for Helicobacter pylori therapies: Compared and contrasted to traditional infectious disease therapyDavid Y Graham, Francis Megraud
Lancet (London, England)|October 23, 2016
Towards effective empirical treatment for Helicobacter pylori eradicationFrancis Megraud, Javier P Gisbert
Diagnostics (Basel, Switzerland)|July 14, 2023
Reply to Kocsmár, É.; Lotz, G. Comment on "Skrebinska et al. Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for <i>Helicobacter pylori</i> Detection? <i>Diagnostics</i> 2022, <i>12</i>, 133"Ilva Daugule, Francis Megraud, Marcis Leja
Helicobacter|August 13, 2025
Helicobacter pylori Infection in Children Versus Adults, Differences in Management Guidelines: Risks and Benefits of Treatment in ChildhoodMatjaž Homan, Zrinjka Mišak, Francis Megraud, et al.
Helicobacter|August 3, 2006
Bioinformatic analysis of Helicobacter pylori XGPRTase: a potential therapeutic targetMegan Duckworth, Armelle Ménard, Francis Megraud, et al.
Gut|March 6, 2023
Empiric use of standard triple therapy in <i>Helicobacter pylori</i> eradication does not require readjustment in the clarithromycin resistance cut-off pointPeter Malfertheiner, Francis Megraud, Theodore Rokkas, et al.
Acta Pharmaceutica (Zagreb, Croatia)|October 13, 2009
Metalloantibiotics: synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pyloriAnwar R Shaikh, Rajani Giridhar, Francis Megraud, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|March 17, 2005
Detection of mutations associated with macrolide resistance in thermophilic Campylobacter spp. by real-time PCRSylvie Vacher, Armelle Menard, Elisabeth Bernard, et al.
Pageof 8